Catalent is named as a contract manufacturer of the drug product for Novo Nordisks Wegovy (semaglutide), a diabetes treatment that has been shown to help patients lose weight
Supply Shortages In late 2024 and early 2025, the UK had significant shortages of GLP-1 medicines, especially: Wegovy, because demand is very high Ozempic, which caused problems for some diabetes patients If you are considering starting treatment, discuss the available options with your doctor
Importantly, visceral fat, also called abdominal fat, was lower in the people who took the supplement
10.1210/er.2004-0001 35 JiangJ.ChangX.NieY.ShenY.LiangX.PengY.et al (2021)
We stand behind every formulation delivered to our patients to be of the highest quality and sterility